Jon Lipsey

Jon Lipsey is the founder of Unfiltered, a media platform covering health, fitness, technology and human performance. He is the former editor of Men's Fitness magazine and has spent more than 20 years reporting on the science and business of the health industry. He has interviewed leading figures across performance medicine, longevity science and sports business.

99 articles published Follow:

BUSINESS

Nike exits boutique fitness with closure of Nike Studios

Nike has shut down all of its Nike Studios locations, ending a three-year experiment in branded boutique fitness. Launched in 2023 in partnership with FitLab, the concept combined HIIT, treadmill running, and strength training classes under the Nike brand. Locations operated in markets including West Hollywood and Austin. Rather than scaling the concept, Nike has…

ByJon LipseyApril 14, 20260Comments

BUSINESS

Marriott partners with Lefay to launch a dedicated wellness brand

Marriott International has entered a joint venture with Italian wellness brand Lefay, bringing the company into its global portfolio as its first brand dedicated exclusively to luxury wellness. The deal combines Lefay’s existing brand, intellectual property, and operating model with Marriott’s global scale, development infrastructure, and loyalty ecosystem. Lefay currently operates two resorts in Italy…

ByJon LipseyApril 13, 20260Comments

TECH

Function acquires Getlabs to expand at-home diagnostics

Function Health has acquired Getlabs, a mobile healthcare platform that dispatches licensed professionals to collect blood samples at a patient’s home, office, or other location. The integration introduces a new option for Function members: either visit one of more than 2,000 lab locations or schedule a home blood draw. The diagnostic process, lab panels, and…

ByJon LipseyApril 12, 20260Comments

TECH

Lume Health adds funding to build cortisol tracker for circadian health

Lume Health has secured fresh funding to advance a wrist-worn device designed to track cortisol and decode circadian health. According to reports, the company has now raised $2.5 million, built a waitlist of more than 5,200 people, and is using the capital to support pre-launch development and scientific validation. That matters because Lume is targeting…

ByJon LipseyApril 2, 20260Comments

NUTRITION

Danone acquires Huel for $1bn to expand functional nutrition portfolio

Danone has agreed to acquire Huel in a deal valued at approximately $1bn, bringing one of the fastest-growing meal replacement brands into a global food portfolio. Huel, founded in the UK, has built a direct-to-consumer business around powdered and ready-to-drink meals designed to provide complete nutrition. The company has scaled rapidly, reaching hundreds of millions…

ByJon LipseyApril 2, 20260Comments

TECH

Perplexity AI enters consumer health AI to deliver real-time medical answers

Perplexity AI is expanding into healthcare, positioning its AI-powered search platform as a tool for delivering real-time medical information and guidance. The company has built its product around an answer engine that retrieves, synthesises and cites information in response to user queries. Applying that model to healthcare introduces a higher-stakes use case, where accuracy, transparency…

ByJon LipseyApril 2, 20260Comments

MIND Vanguard

The race to copy your brain before AI replaces you

Christian Larsen does not hedge when the conversation turns to AI. If a superintelligent AI “species” emerges, one that is faster, more capable and operating at a fundamentally different level of capacity, he believes the outcome is already decided. “There’s no question that they will have the upper hand,” he says. Not in ten years.…

ByJon LipseyApril 2, 20260Comments

MIND

Mave Health raises $2.1m to launch brain-stimulation headset for focus and mood regulation

Mave Health has raised $2.1 million to develop a wearable headset designed to improve attention, mood and stress regulation through non-invasive brain stimulation. The company is preparing to launch the device in 2026, targeting consumers looking for tools to manage cognitive performance and emotional state in real time. The funding reflects growing interest in neurotechnology…

ByJon LipseyMarch 30, 20260Comments

HEALTH Obesity crisis

Eli Lilly advances retatrutide to Phase 3 to expand next-generation multi-hormone obesity therapeutics

Eli Lilly is progressing its experimental obesity and type 2 diabetes drug retatrutide into Phase 3 trials, following late-stage data showing significant weight loss and metabolic improvements. Retatrutide belongs to a new class of drugs known as triple agonists, targeting three key metabolic pathways simultaneously. In earlier trials, the drug demonstrated weight loss outcomes exceeding…

ByJon LipseyMarch 26, 20260Comments

BUSINESS

Solo60 raises $3.3M to scale app-bookable micro-gyms and rethink gym real estate

London-based Solo60 has raised £2.5 million ($3.3 million) to accelerate expansion across the UK and support longer-term international growth. The company lets consumers, personal trainers and influencers book private training spaces by the hour through a mobile app, rather than joining a conventional shared gym. That matters because Solo60 is not simply opening smaller gyms.…

ByJon LipseyMarch 26, 20260Comments

Jon Lipsey

Newsletter

Sign Up to Our Newsletter